KCNA inhibitors are a class of chemical compounds that specifically target and inhibit the function of KCNA channels, which are voltage-gated potassium (Kv) channels. These channels are crucial for maintaining and regulating the electrical activity of cells, particularly in excitable tissues like neurons and muscles. KCNA channels, also known as Kv1 channels, are part of a large family of potassium channels that open in response to changes in membrane potential, allowing potassium ions to flow out of the cell. This flow of potassium helps repolarize the cell membrane following an action potential, thereby restoring the resting membrane potential and ensuring proper cellular excitability. Inhibiting KCNA channels disrupts this process, providing insights into how potassium flux influences cellular excitability, action potential duration, and signal propagation.
The mechanism of KCNA inhibitors generally involves binding to key regions of the Kv1 channel, such as the pore domain or voltage-sensing domain, to block the flow of potassium ions. Structurally, these inhibitors can act by occluding the potassium-conducting pore or by altering the channel's ability to respond to changes in membrane voltage, thus preventing channel opening. Some KCNA inhibitors may be selective for specific isoforms of the Kv1 family, enabling precise control over individual channel subtypes in various research contexts. By studying KCNA inhibitors, researchers gain valuable knowledge about the regulation of ion channel activity, the role of potassium currents in controlling cellular electrical properties, and the broader effects of potassium channel inhibition on physiological processes like neuronal firing, muscle contraction, and cellular signaling. These inhibitors are essential tools for exploring the function of Kv channels in both basic and applied research related to cellular electrophysiology and ion transport.
VOIR ÉGALEMENT...
| Nom du produit | CAS # | Ref. Catalogue | Quantité | Prix HT | CITATIONS | Classement | 
|---|---|---|---|---|---|---|
| Quinidine | 56-54-2 | sc-212614 | 10 g | $102.00 | 3 | |
| La quinidine est un bloqueur des canaux potassiques voltage-gated qui inhibe divers canaux potassiques, notamment le KVβ.3. Elle stabilise le potentiel membranaire, réduisant l'excitabilité des tissus cardiaques et affectant ainsi indirectement le rôle régulateur de KVβ.3 dans le rythme cardiaque. | ||||||
| Amiodarone | 1951-25-3 | sc-480089 | 5 g | $312.00 | ||
| L'amiodarone agit sur plusieurs cibles, notamment les canaux potassiques, ce qui entraîne une prolongation de la phase 3 du potentiel d'action cardiaque. Son large spectre d'activité comprend la modulation des canaux KVβ.3, ce qui a un impact sur la conductivité électrique et le potentiel arythmique du cœur. | ||||||
| 4-Aminopyridine | 504-24-5 | sc-202421 sc-202421B sc-202421A | 25 g 1 kg 100 g | $37.00 $1132.00 $120.00 | 3 | |
| La 4-Aminopyridine est connue pour bloquer les canaux potassiques voltage-gated, augmentant ainsi la libération de neurotransmetteurs. Ce bloqueur inhibe spécifiquement le KVβ.3 parmi d'autres sous-unités, ce qui peut entraîner des modifications de la conduction nerveuse et du contrôle musculaire. | ||||||